1. EP-1480: A comprehensive analysis of immuno- and immunoradiotherapy trial design developments from 2000-2014. (April 2016) Authors: Raby, S.; Connell, C.; Janowitz, T. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. RAD51 and BRCA2 enhance oncolytic adenovirus type 5 activity in ovarian cancer. (July 2016) Authors: Tookman, L.; Ashley, B.; Connell, C.; Bridge, G.; Ingemarsdotter, C.; Dowson, S.; Shibata, A.; Michelle, L.; Martin, S.; McNeish, I. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0217 Identification of distinct disease activity trajectories in patients with rheumatoid arthritis receiving tofacitinib over 12 months. (12th June 2018) Authors: Bykerk, V. P.; van Vollenhoven, R.; Connell, C.; Gruben, D.; Fallon, L.; Woolcott, J.; Keystone, E. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0220 Radiographic Progression in Modern RA Trials is Still a Robust Outcome: Results of Comprehensive Sensitivity Analysis in Two Phase 3 Trials with Tofacitinib. (9th June 2015) Authors: van der Heijde, D.; Connell, C.; Bradley, J.; Gruben, D.; Strengholt, S.; Landewé, R.B. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0140 Tofacitinib (CP-690, 550), an oral janus kinase inhibitor: Analysis of gastrointestinal adverse events across the rheumatoid arthritis clinical programme. (23rd January 2014) Authors: Lee, E.B.; Curtis, J.R.; Riese, R.; Connell, C.; Chew, R.; Boy, M.; Maller, E.; Su, C.; Wang, L.; Bradley, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0165 Long-Term Radiographic and Patient-Reported Outcomes Based on Clinical Disease Activity Index Responses with Tofacitinib at 6 Months. (15th July 2016) Authors: Strand, V.; Kavanaugh, A.; Kivitz, A.; van der Heijde, D.; Kwok, K.; Akylbekova, E.; Soonasra, A.; Snyder, M.; Connell, C.; Bananis, E.; Smolen, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0200 Effect of Methotrexate Dose on The Efficacy of Tofacitinib: Treatment Outcomes from A Phase 3 Clinical Trial of Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Fleischmann, R.; Mease, P.; Schwartzman, S.; Hwang, L.-J.; Soma, K.; Connell, C.; Takiya, L.; Bananis, E. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗